Hemodynamics, fluids & transfusion
Advances in the Management of Cardiogenic Shock
Authors' conclusion
CS results in short-term mortality exceeding 30% despite standard therapy.
Study context
- Population
- Patients with cardiogenic shock (CS)
Main finding
As reported in the abstract
- CS results in short-term mortality exceeding 30% despite standard therapy
- Heart failure-related CS now predominates at many centers, although acute myocardial infarction (AMI) has been the focus of most CS research
- SCAI Shock Classification categorizes patients with or at risk of CS by shock severity, which predicts mortality
- Vasopressors and inotropes titrated to restore arterial pressure and perfusion are the cornerstone of initial medical therapy
- RCTs have not demonstrated better survival with routine use of temporary mechanical circulatory support (MCS) in CS
Original publication
Advances in the Management of Cardiogenic Shock. Crit Care Med. Published 15 May 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →